Interventions of Interest:
- resmetirom (Madrigal Pharmaceuticals, Inc.)
- obeticholic acid (Ocaliva or “OCA”, Intercept Pharmaceuticals)
For questions, please contact Liis Shea, Program Director, at lshea@icer.org.
View the Key Stakeholder List.
Assessment Status
Open
Upcoming Milestone
Evidence ReportView
Interventions of Interest:
For questions, please contact Liis Shea, Program Director, at lshea@icer.org.
View the Key Stakeholder List.
Midwest CEPAC
The Midwest CEPAC’s 2023 public meeting on NASH.
Register for Meeting
Public Comments
Closed